FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, CEL-SCI's Trailing 12-Month Free Cash Flow is $-18.14 Mil, and Market Cap is $18.18 Mil. Therefore, CEL-SCI's FCF Yield % for today is -99.79%.
The historical rank and industry rank for CEL-SCI's FCF Yield % or its related term are showing as below:
CVM'
s FCF Yield % Range Over the Past 10 Years
Min: -99.79 Med: 0 Max: 0
Current: -99.79
CVM's FCF Yield % is ranked worse than 81.89% of 1496
companies
in the Biotechnology industry
Industry Median: -15.915
vs CVM: -99.79
The historical data trend for CEL-SCI's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, CEL-SCI's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CEL-SCI's FCF Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CEL-SCI's FCF Yield % distribution charts can be found below:
* The bar in red indicates where CEL-SCI's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CEL-SCI FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
CEL-SCI FCF Yield % Related Terms
Thank you for viewing the detailed overview of CEL-SCI's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CVM has been successfully added to your 